Navigation Links
Abaxis Reports Record Revenues and Operating Income for the Second Quarter of Fiscal 2009
Date:10/27/2008

n dial (877) 356-5706 or (706) 643-0580 to access the conference call, or can listen via a live Internet web cast, which is available in the Investor Relations section of the company's website at http://www.abaxis.com. A replay of the call is available by visiting http://www.abaxis.com for the next 30 days or by calling (800) 642-1687 or (706) 645-9291, access code 69576563, through October 30, 2008. This press release is also available prior to and after the call via Abaxis' website or the Securities and Exchange Commission's website at http://www.sec.gov.

About Abaxis

Abaxis develops, manufactures and markets portable blood analysis systems for use in any veterinary or human patient-care setting to provide clinicians with rapid blood constituent measurements. The system consists of a compact, 5.1 kilogram (11.2 pounds), portable analyzer and a series of single-use plastic discs, called reagent discs that contain all the chemicals required to perform a panel of up to 13 tests on veterinary patients and 14 tests on human patients. The system can be operated with minimal training and performs multiple routine tests on whole blood, serum or plasma samples. The system provides test results in less than 12 minutes with the precision and accuracy equivalent to a clinical laboratory analyzer.

Use of Non-GAAP Financial Measures

To supplement its financial statements presented in accordance with United States generally accepted accounting principles (GAAP), Abaxis uses operating income per share. This non-GAAP financial presentation is not a measurement of performance under GAAP in the United States of America. Management uses this measure in comparing Abaxis' operating results with historical performance and believes it provides meaningful and comparable information to management and investors to assi
'/>"/>

SOURCE Abaxis, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Abaxis, Inc. to Present at the Sidoti & Companys Seventh Annual West Coast Emerging Growth Institutional Investor Forum
2. Abaxis Reports Financial Performance for the First Quarter of Fiscal 2009
3. Abaxis to Report Third Quarter Fiscal 2008 Financial Results Thursday, January 31, 2008
4. Abaxis CEO Clint Severson Named Entrepreneur of the Year by Forbes Magazine
5. Abaxis to Present at the Sidoti & Company Sixth Annual San Francisco Institutional Investor Forum Conference
6. Trubion Reports Re-treatment Results Following Phase 1/2a and Phase 2b Studies Evaluating TRU-015 for Rheumatoid Arthritis
7. BioCryst Reports Results From the First-Ever Completed Active-Controlled Phase 2 Study in Hospitalized Influenza
8. International Drug & Explosive Detection Firm Identa Corp Releasing: Jant Pharmacal Corporation Reports Successful Market Penetration of the Accutest(R) IDenta Co-brand in the United States and Oversees
9. Anadys Pharmaceuticals Reports Third Quarter 2008 Financial Results and Highlights
10. Aware, Inc. Reports Third Quarter 2008 Financial Results
11. Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Second Quarter and First Six Months of Fiscal 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... Health Industry Issues in 2010, puts healthcare cost control at the ... ahead. , ... New York, NY (Vocus) December ... Health Industry Issues in 2010, puts healthcare cost ... for the year ahead. , , , , ,“Healthcare typically lags ...
(Date:12/17/2009)... TOLEDO will be exhibiting the latest particle size distribution technologies, ... Pharmaceutical Scientists’ Annual Meeting, AAPS 2010. , ... ... be exhibiting at the American Association of Pharmaceutical Scientists’ ... 14-18, 2010. Visit Booth 612 at AAPS 2010 to ...
(Date:12/16/2009)... University of East Anglia (UEA) could contribute to the ... to generate clean electricity. , Published today by the ... of Sciences (PNAS), the researchers have demonstrated for ... survive by ,breathing rocks,. , The findings could be ... technologies such as fuel cells, or ,bio-batteries, powered by ...
(Date:12/16/2009)... -- Martek Biosciences Corporation (Nasdaq: MATK ) today ... fiscal year ended October 31, 2009. Revenues for the ... million in the fourth quarter of fiscal 2008. Net ... for the fourth quarter of fiscal 2009, a 5% ... share, in last year,s fourth quarter. The fourth ...
Breaking Biology Technology:Squeezing Costs out of Healthcare Tops PricewaterhouseCoopers' List of Health Industry Issues in 2010, 2Squeezing Costs out of Healthcare Tops PricewaterhouseCoopers' List of Health Industry Issues in 2010, 3Squeezing Costs out of Healthcare Tops PricewaterhouseCoopers' List of Health Industry Issues in 2010, 4Squeezing Costs out of Healthcare Tops PricewaterhouseCoopers' List of Health Industry Issues in 2010, 5Particle Size Distribution Technologies at American Association of Pharmaceutical Scientists (AAPS) Annual Meeting 2010 2'Rock-breathing' bacteria could generate electricity and clean up oil spills 2Martek Announces Fourth Quarter and FY 2009 Financial Results 2Martek Announces Fourth Quarter and FY 2009 Financial Results 3Martek Announces Fourth Quarter and FY 2009 Financial Results 4Martek Announces Fourth Quarter and FY 2009 Financial Results 5Martek Announces Fourth Quarter and FY 2009 Financial Results 6Martek Announces Fourth Quarter and FY 2009 Financial Results 7Martek Announces Fourth Quarter and FY 2009 Financial Results 8Martek Announces Fourth Quarter and FY 2009 Financial Results 9Martek Announces Fourth Quarter and FY 2009 Financial Results 10Martek Announces Fourth Quarter and FY 2009 Financial Results 11Martek Announces Fourth Quarter and FY 2009 Financial Results 12Martek Announces Fourth Quarter and FY 2009 Financial Results 13Martek Announces Fourth Quarter and FY 2009 Financial Results 14
... of ApoA-I/HDL drugs to reverse atherosclerosis enters the clinic ... TSX ... (TSX:RVX) announced today that it has received approval by,the US Food ... oral RVX-208 in the USA. RVX-208 is a novel first-in-class small,molecule ...
... Inc. (Nasdaq: LXRX ) today announced that a ... Capital Markets,Healthcare Conference panel Going With Your Gut: New ... in New York, New York on,Wednesday, December 12, 2007 ... webcast of the panel presentation may be accessed on,Lexicon,s ...
... Novel Drug Enhances Pharmacokinetic Properties of Co- Administered ... ... Md., Dec. 7 Sequoia Pharmaceuticals, Inc.,announced today that it ... States Food and Drug Administration to,begin human clinical trials with ...
Other Biology Technology:FDA Grants Resverlogix Approval to Commence a Phase 1 Clinical Trial for RVX-208 2FDA Grants Resverlogix Approval to Commence a Phase 1 Clinical Trial for RVX-208 3Lexicon Pharmaceuticals to Present at RBC Capital Markets Healthcare Conference 2
(Date:12/16/2009)... than 4 billion years before humans showed up, and ... That suggests they may have something to teach us. ... Prof. Eshel Ben-Jacob of the Raymond and Beverly Sackler ... of bacteria, presents compelling evidence to suggest there may ... opt for the swine flu H1N1 shot. , In ...
(Date:12/16/2009)... YORK, Dec. 1 iQor, a global provider ... the 2009 InfoWorld 100 Awards Top 100 ... TeQ21. This was the first submission for iQor. ,, ... list of companies," said Vikas Kapoor, president and CEO ... do business, allowing us to work faster, smarter and ...
(Date:12/16/2009)... Calif. and PALM HARBOR, Fla., Dec. 2 ... Bulletin Board: CICI), a leading supplier of ... in the financial industry* and the recognized ... Systems Inc. ("Docubase"), a leading International Electronic ... that they have entered an agreement to ...
Breaking Biology News(10 mins):Bacteria wouldn't opt for a swine flu shot 2Bacteria wouldn't opt for a swine flu shot 3iQor Named to InfoWorld 100 List of Top IT Projects of 2009 2CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 2CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 3CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 4Apes Love a Good Laugh Too 47960 1Apes Love a Good Laugh Too 47960 2Apes Love a Good Laugh Too 47960 3Palliative Medicine to be official journal of the Association for Palliative Medicine 47956 1FAO IAEA Symposium to address animal production and health 8720 1FAO IAEA Symposium to address animal production and health 8720 2
... Although naturally occurring smallpox was eradicated in 1977, there ... laboratory and release it into the population. Under such ... for universal administration. In a study published in the ... Medicine , researchers found that lifetime protection is obtained ...
... World records tumbled at the Beijing Olympics. Usain Bolt ... tenths of a second off each. People have been ... which made marathon runner Mark Denny, from Stanford University, ... account for these dramatic improvements. He also wondered whether ...
... Health Science Center Institute of Biosciences and Technology, ... a bacterial pathogen interacts with the blood coagulation ... (MRSA) infections, a finding that could aid ... Their work appears November 28 in the ...
Other Biology News:New study indicates smallpox vaccination effective for decades 2100-meter sprint world record could go as low as 9.48 seconds 2
... Kit containing Vaginal Keratinocyte Progenitors, Rabbit, ... 20% FBS and 10% DMSO at passage ... of optimized medium.This cell culture is supplied ... to provide an additional 6 months of ...
... MagneGST™ Protein Purification System provides a ... the purification of glutathione-S-transferase (GST) fusion ... Particles) are used to isolate GST-tagged ... cleared lysate using either a manual ...
... Useful for the mechanical harvesting of cells ... ensures even contact with the growth surface ... 75cm flasks • Individually wrapped • Sterilized ... This CLS number is a new product ...
... Assay Kits are ideal for studying ... compounds using fluorescence polarization (FP) The ... glutathione transferase to the ligand binding ... and a proprietary, fluorescently-tagged progesterone ligand, ...
Biology Products: